Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well sunitinib works in treating patients with advanced
malignant mesothelioma of the pleura. Sunitinib may stop the growth of tumor cells by
blocking some of the enzymes needed for their growth.